PMC:7600245 / 64922-65093
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T308 | 139-147 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T19308 | 31-41 | Chemical | denotes | levamisole | http://purl.obolibrary.org/obo/CHEBI_6432 |
| T72066 | 88-98 | Chemical | denotes | budesonide | http://purl.obolibrary.org/obo/CHEBI_3207 |
| T64107 | 99-109 | Chemical | denotes | formoterol | http://purl.obolibrary.org/obo/CHEBI_5147 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T501 | 0-171 | Sentence | denotes | As of now, orally administered levamisole is being studied alone or in combination with budesonide/formoterol inhaler for the treatment of COVID-19 in few clinical trials. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2038 | 31-41 | Chemical | denotes | levamisole | MESH:D007978 |
| 2039 | 88-98 | Chemical | denotes | budesonide | MESH:D019819 |
| 2040 | 99-109 | Chemical | denotes | formoterol | MESH:D000068759 |
| 2043 | 139-147 | Disease | denotes | COVID-19 | MESH:C000657245 |